Remifentanil Hydrochloride Market

Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.

Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.

Remifentanil Hydrochloride Market contains market size and forecasts of Remifentanil Hydrochloride in global, including the following market information:

Global Remifentanil Hydrochloride Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Remifentanil Hydrochloride Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Remifentanil Hydrochloride companies in 2021 (%)

The global Remifentanil Hydrochloride market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

1mg/Pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Remifentanil Hydrochloride include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma and AMRI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Remifentanil Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Remifentanil Hydrochloride Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Remifentanil Hydrochloride Market Segment Percentages, by Type, 2021 (%)

1mg/Pcs

2mg/Pcs

5mg/Pcs

Global Remifentanil Hydrochloride Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Remifentanil Hydrochloride Market Segment Percentages, by Application, 2021 (%)

Endotracheal Intubation Operation

Neurosurgery

Outpatient Surgery

Postoperative Analgesia

Other

Global Remifentanil Hydrochloride Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Remifentanil Hydrochloride Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Remifentanil Hydrochloride revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Remifentanil Hydrochloride revenues share in global market, 2021 (%)

Key companies Remifentanil Hydrochloride sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Remifentanil Hydrochloride sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

Macfarlan Smith

Abbott

Mylan

Arevipharma

AMRI